SCHEMBL7211307

SCHEMBL7211307

O=C(O)C/C=C\C1CCNCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP2D6 P10635 1/20 0.42
GABRA5 P31644 3/20 0.40
GABRB2 P47870 3/20 0.40
GABRA1 P14867 2/20 0.40
GABRA4 P48169 2/20 0.40
TSHR P16473 2/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRE P78334 1/20 0.40
PMP22 Q01453 1/20 0.40
GABRA6 Q16445 1/20 0.40
GABRG1 Q8N1C3 1/20 0.40
GABRG3 Q99928 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211311 1.00 ALOX15 (0.42) ALOX15ALDH1A1CYP2D6GABRA5GABRB2
SCHEMBL9065657 0.85
SCHEMBL10891519 0.85
SCHEMBL17651119 0.79 ALDH1A1 (0.46) ALOX15ALDH1A1CYP2D6
SCHEMBL18173431 0.79 GABRA5 (0.43) ALOX15ALDH1A1CYP2D6GABRA5GABRB2
SCHEMBL21001913 0.72 TSHR (0.44) GABRA5GABRB2GABRA1GABRA4TSHR
SCHEMBL9408336 0.72 ALDH1A1 (0.38) ALOX15ALDH1A1CYP2D6
Hydrochloric Acid SCHEMBL422774 0.71 TSHR (0.43) GABRA5GABRB2GABRA1GABRA4TSHR
Hydrochloric Acid SCHEMBL422775 0.71 TSHR (0.43) GABRA5GABRB2GABRA1GABRA4TSHR
SCHEMBL27055234 0.71 ALDH1A1 (0.46) ALOX15ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030831-A4 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES AVENTIS PHARM PROD INC (US) 2003-01-02 EP disclosed
US-6180759-B1 PREPARING AZACYCLOALKANOYLPSEUDOTETRAPEPTIDES COMPRISING COUPLING A DIPEPTIDE WITH A PSEUDODIPEPTIDE; FOR EXAMPLE, N-(N-ETHYL-N-(1-OXO-4-(4-PIPERIDINYL)BUTYL)GLYCYL)-(L)-ALPHA-ASPARTYL-3 -CYCLOHEXYL-(L)-ALANINEAMIDE; USE AS ANTICOAGULANTS AVENTIS PHARMACEUTICALS PRODUCTS INC. 2001-01-30 US disclosed
EP-1030831-A1 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES Aventis Pharmaceuticals Products Inc. (US) 2000-08-30 EP disclosed
WO-1999019294-A1 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES AVENTIS PHARMACEUTICALS PRODUCTS INC. LEGAL/PATENTS (US) 1999-04-22 WO disclosed